Production and preparation of human leukocyte interferon

K.E. Mogensen1,2, Kari Cantell1,2
1Institut de Recherches Scientifiques sur le Cancer, 94800 Villejuif, France
2Central Public Health Laboratory, Mannerheimintie 166, SF00280, Helsinki 28, Finland

Tài liệu tham khảo

Adams, 1975, Spontaneous interferon production and Epstein-Barr antigen expression in human lymphoid cell lines, J. gen. Virol., 28, 219, 10.1099/0022-1317-28-2-219 Adams, 1975, Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon, J. gen. Virol., 28, 207, 10.1099/0022-1317-28-2-207 Anfinsen, 1974, Partial purification of human interferon by affinity chromatography, 71, 3139 Bagglioni, 1969, Resolution of granules from rabbit heterophil leukocytes into distinct populations by zonal sedimentation, J. Cell Biol., 40, 529, 10.1083/jcb.40.2.529 Banatvala, 1971, Interferon response to Sendai and Rubella viruses in human foetal cultures, leukocytes and placental cultures, J. gen. Virol., 13, 193, 10.1099/0022-1317-13-2-193 Baron, 1963, Circulating interferon in mice after intravenous injection of virus, Science, 141, 1061, 10.1126/science.141.3585.1061 Berg, 1975, Affinity chromatography of human leukocyte and diploid cell interferons on sepharose-bound antibodies, J. Immunol., 114, 640, 10.4049/jimmunol.114.2_Part_1.640 Besancon, 1974, Affinity of murine and human interferon for Concanavalin A, J. Immunol., 113, 1061, 10.4049/jimmunol.113.3.1061 Borecky, 1974, Electrophoretic profiles and activities of human interferon in heterologous cells, Intervirology, 3, 369, 10.1159/000149774 Bose, 1976, Apparent dispensability of the carbohydrate moiety of human interferon for antiviral activity, J. biol. Chem., 251, 1659, 10.1016/S0021-9258(17)33699-2 Bucknall, 1967, Species specificity of interferons: a misnomer?, Nature Lond., 216, 1022, 10.1038/2161022a0 Cantell, 1961, Mumps virus, Adv. Virus Res., 8, 123, 10.1016/S0065-3527(08)60684-3 Cantell, 1970, Preparation of human leukocyte interferon, 6 Cantell, 1970, Attempts to prepare interferon in continuous cultures of human leukocytes, Ann. N.Y. Acad. Sci., 173, 160, 10.1111/j.1749-6632.1970.tb53403.x Cantell, 1975, Towards clinical use of interferon, 18, 614 Cantell, 1974, Human leukocyte interferon: production, purification, stability and animal experiments, 35 Cantell, 1973, Circulating interferon in rabbits after administration of human interferon by different routes, J. gen. Virol., 20, 97, 10.1099/0022-1317-20-1-97 Cantell, 1976, Pharmacokinetics of human leukocyte interferon, J. Infect. Dis., 133, A6, 10.1093/infdis/133.Supplement_2.A6 Cantell, 1968, How much interferon can be prepared in human leukocyte suspensions?, 223 Cantell, 1971, Substitution of milk for serum in the production of human leukocyte interferon, App. Microbiol., 22, 625, 10.1128/AEM.22.4.625-628.1971 Cecil, 1959, The sulphur chemistry of proteins, Adv. Protein Res., 14, 256 Chen, 1976, Nature of the molecular heterogeneity of human leukocyte interferon, J. Virol., 19, 425, 10.1128/JVI.19.2.425-434.1976 Cole, 1976, Induction of interferon in ovine and human lymphocyte cultures by mycoplasmas, Infection Immunity, 14, 88, 10.1128/IAI.14.1.88-94.1976 Davey, 1974, Hydrophobic interaction of human interferon with Concanavalin A-agarose, J. biol. Chem., 249, 6354, 10.1016/S0021-9258(19)42261-8 Davey, 1976, Purification and characterization of mouse interferon with novel affinity sorbents, J. Virol., 17, 439, 10.1128/JVI.17.2.439-445.1976 DeMaeyer, 1969, Interferon synthesis in X-irradiated animals III. The high radiosensitivity of myxovirus-induced circulating interferon production, 131, 36 DeMaeyer-Guignard, 1969, Interferon synthesis in X-irradiated animals. IV. Donor type serum interferons in rat-to-mouse radiation chimeras injected with Newcastle disease virus, 63, 732 DeMaeyer-Guignard, 1971, Effect of antilymphocytic serum on circulating interferon in mice, as a function of the inducer, Nature New Biol., 229, 212, 10.1038/newbio229212a0 Desmyter, 1968, A human interferon that crosses the species line, 59, 69 Desmyter, 1976, Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells, Virology, 70, 451, 10.1016/0042-6822(76)90286-5 Dorner, 1973, Interferon: evidence for its glycoprotein nature, 70, 1981 Duc-Goiran, 1971, Studies on virus-induced interferons produced by the human amniotic membrane and white blood cells, Arch. ges. Virusforsch., 34, 232, 10.1007/BF01242997 Edy, 1974, Stabilization of mouse and human interferons by acid pH against inactivation due to shaking and guanidine hydrochloride, 146, 249 Emödi, 1975, Human interferon therapy for Herpes zoster in adults, Scand. J. infect. Dis., 7, 1, 10.3109/inf.1975.7.issue-1.01 Epstein, 1976, The ability of macrophages to augment in vitro mitogen and antigen stimulated production of interferon and other mediators of cellular immunity by lymphocytes, 201 Falcoff, 1965, Estimation du poids moléculaire de l'interféron produit par les globules blancs humains, C.R. Acad. Sci. D. (Paris), 260, 5405 Falcoff, 1966, Production en masse, purification paritelle et caractérisation d'un interféron destiné a des essais thérapeutiques humains, Ann. Inst. Pasteur (Paris), 111, 562 Falcoff, 1969, Interférons humains induits in vitro par des polynucléotides synthétiques, Biochim. biophys. acta, 174, 108, 10.1016/0005-2787(69)90233-0 Falcoff, 1972, Some properties of virus and immune-induced human lymphocyte interferons, J. gen. Virol., 16, 251, 10.1099/0022-1317-16-2-251 Fantes, 1969, Partial purification and properties of human leukocyte interferon, 181 Fantes, 1970, Purification and properties of human interferon, Ann. N.Y. Acad. Sci., 173, 118, 10.1111/j.1749-6632.1970.tb53398.x Fantes, 1974, Human leukocyte interferon: properties and purification, 48 Fantes, 1964, Some similarities between a viral inhibitor of plant origin and chick interferon, Nature Lond., 203, 1048, 10.1038/2031048a0 Glasgow, 1966, Leukocytes and interferon in the host response to viral infections II. Enhanced interferon response of leukocytes from immune animals, J. Bacteriol., 91, 2185, 10.1128/JB.91.6.2185-2191.1966 Goore, 1973, Human leukocyte interferon produced by use of an antibody-free serum fraction, Appl. Microbiol., 25, 325, 10.1128/AEM.25.3.325-326.1973 Graff, 1970, Interferon, Trans. NY Acad. Sci., 32, 545, 10.1111/j.2164-0947.1970.tb02730.x Green, 1969, Immunespecific induction of interferon production in cultures of human blood lymphocytes, Science, 164, 1415, 10.1126/science.164.3886.1415 Gresser, 1961, Production of interferon by suspensions of human leukocytes, 108, 799 Gresser, 1974, Pronounced antiviral activity of human interferon on bovine and porcine cells, Nature Lond., 251, 543, 10.1038/251543a0 Hadhazy, 1969, Serum requirement for interferon production by suspended human leukocytes: studies on action of serum, J. gen. Virol., 5, 351, 10.1099/0022-1317-5-3-351 Harris, 1966, Artificial heterokaryons of animal cells from different species, J. Cell Sci., 1, 1, 10.1242/jcs.1.1.1 Haschen, 1975, Proteases in specific cell types, 4, 251 Havell, 1975, Two antigenically distinct species of human interferon, 72, 2185 Henle, 1965, Evidence for a persistent viral infection in a cell-line derived from Burkitt's lymphoma, J. Bacteriol., 89, 252, 10.1128/JB.89.1.252-258.1965 Ho, 1973, Animal viruses and interferon formation, 29 Horowitz, 1970, Interferon production and protein synthesis in human leukocytes, 9 Jankowski, 1975, Molecular structure of human fibroblast and leukocyte interferons: Probe by lectin and hydrophobic chromatography, J. Virol., 16, 1124, 10.1128/JVI.16.5.1124-1130.1975 Klein, 1972, Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid lines to superinfection with EB virus, Int. J. Cancer, 10, 44, 10.1002/ijc.2910100108 Knight, 1975, Heterogeneity of purified mouse interferons, J. biol. Chem., 250, 4139, 10.1016/S0021-9258(19)41397-5 Knight, 1976, Interferon: purification and initial characterization from human diploid cells, 73, 520 Kono, 1967, Inferferon-like inhibitor produced in bovine leukocyte cultures after inoculation with endotoxin, Arch. ges. Virusforsch., 21, 276, 10.1007/BF01241451 Kuznetsov, 1973, Human leukocyte interferon preparation, J. infect. Dis., 128, 261 Lee, 1969, Interferon production by human leukocytes in vitro: Some biological characteristics, Appl. Microbiol., 18, 731, 10.1128/AEM.18.5.731-735.1969 Lee, 1965, Production of interferon by human mononuclear leukocytes, Proc. Soc. expl. Biol. Med., 118, 190, 10.3181/00379727-118-29794 Levy-Koenig, 1970, Immunology of interferons. II. Hetero-specific activities of human interferons and their neutralization by antibody, J. Immunol., 104, 791, 10.4049/jimmunol.104.4.791 Levy-Koenig, 1970, Immunology of interferons. I. Immune response to protective and non-protective interferons, J. Immunol., 104, 785, 10.4049/jimmunol.104.4.785 Lockart, 1973, Criteria for acceptance of a viral inhibitor as an interferon and a general description of the biological properties of known interferons, 11 Manthey, 1974, Humaninterferon als Therapeutikum, Behring Inst. Mitteil., 54, 81 Marshall, 1972, Inactivation of interferon: the effect of protonation, Virology, 48, 607, 10.1016/0042-6822(72)90074-8 Matsuo, 1974, Production and purification of human leukocyte interferon, Japan. J. Microbiol., 18, 21, 10.1111/j.1348-0421.1974.tb00739.x Merigan, 1973, Non-viral substances which induce interferon, 45 Merigan, 1965, Purification and characterization of vertebrate interferons, J. mol. Biol., 13, 679, 10.1016/S0022-2836(65)80135-8 Mogensen, 1973, Stability of human leukocyte interferon towards heat, Acta path. microbiol. scand., 81B, 382 Mogensen, 1974, Human leukocyte interferon: a role for disulphide bonds, J. gen. Virol., 22, 95, 10.1099/0022-1317-22-1-95 Mogensen, 1974, Loss of specific antigenicity on carboxymethylation of mercaptoethanol-reduced interferon of human leukocyte origin, Intervirology, 2, 52, 10.1159/000149405 Mogensen, 1974, No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits, Acta path. microbiol. scand., 82B, 305 Mogensen, 1975, Raising antibodies to human leukocyte interferon, Acta path. microbiol. scand., 83B, 443 Moore, 1967, Culture of normal human leukocytes, J. Am. med. Ass., 199, 519, 10.1001/jama.1967.03120080053007 Paucker, 1975, Multiple active sites on human interferons, 72, 4587 Pyhälä, 1974, Clearance of human interferon in rabbits induced to make rabbit interferon, 146, 394 Rassiga-Pidot, 1972, Human leukocyte interferon: the variation in normals and correlation with PHA transformation, 140, 1263 Rassiga-Pidot, 1974, In vitro leukocyte interferon production in patients with Hodgkin's disease, Cancer Res., 34, 2995 Ray, 1970, The ontogeny of interferon production by human leukocytes, J. Pediatr., 76, 94, 10.1016/S0022-3476(70)80136-6 Schonne, 1970, The properties of interferon IV. Isoelectric focusing of rabbit interferon (NDV-RK13), 61 Stancek, 1970, Iso-electric components of mouse, human and rabbit interferon, Virology, 41, 740, 10.1016/0042-6822(70)90438-1 Stewart, 1974, Renaturation of inactivated interferons: requirements for reduction of a major component; lack of requirements for reduction of a minor component, J. gen. Virol., 24, 567, 10.1099/0022-1317-24-3-567 Stewart, 1975, Distinct molecular species of human interferons: requirements for stabilization and reactivation of human leukocyte and fibroblast interferons, J. gen. Virol., 26, 327, 10.1099/0022-1317-26-3-327 Stewart, 1975, Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation and cross-species antiviral activity, Virology, 67, 68, 10.1016/0042-6822(75)90403-1 Stewart, 1976, Identification of the cell multiplication inhibitory factors in interferon preparations as interferons, Nature Lond., 262, 300, 10.1038/262300a0 Strander, 1969, Production of interferon in serum-free human leukocyte suspensions, Appl. Microbiol., 18, 810, 10.1128/AEM.18.5.810-815.1969 Strander, 1969, Effect of serum on cells producing hemolytic antibodies in short-term experiments in vitro, J. Immunol., 102, 602, 10.4049/jimmunol.102.3.602 Strander, 1971, Production of interferon by suspended human leukocytes Strander, 1966, Production of interferon by human leukocytes in vitro, Ann. med. expl. biol. fenn., 44, 265 Strander, 1967, Further studies on the production of interferon by human leukocytes in vitro, Ann. med. expl. biol. fenn., 45, 20 Strander, 1974, Studies on antiviral and antitumor effects of human leukocyte interferon in vitro and in vivo, 49 Strander, 1973, Systemic administration of potent interferon to man, J. natn. Cancer Inst., 51, 733, 10.1093/jnci/51.3.733 Strander, 1975, Production of human lymphoblastoid interferon, J. clin. Microbiol., 1, 116, 10.1128/JCM.1.1.116-117.1975 Sulkowski, 1976, Interaction of human interferons with immobilized hydrophobic amino acids and dipeptides, J. biol. Chem., 251, 5381, 10.1016/S0021-9258(17)33172-1 Swart, 1969, Inverse relationship of interferon production and virus content in cell lines from Burkitt's lymphoma and acute leukemias, J. natn. Cancer Inst., 42, 941 Tackett, 1970, Interferon standards, 277 Törmä, 1976, Purification and characterization of human leukocyte interferon components, J. biol. Chem., 251, 4810, 10.1016/S0021-9258(17)33187-3 Tovell, 1971, Kinetics of interferon production in human leukocyte suspensions, J. gen. Virol., 13, 485, 10.1099/0022-1317-13-3-485 Valenta, 1970, Human interferon I. Production, 17 Valle, 1975, Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons, J. Immunol., 115, 230, 10.4049/jimmunol.115.1.230 Wheelock, 1965, Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin, Science, 149, 310, 10.1126/science.149.3681.310 Wheelock, 1966, Virus replication and high-titered interferon production in human leukocyte cultures inoculated with Newcastle disease virus, J. Bacteriol., 92, 1415, 10.1128/JB.92.5.1415-1421.1966 Wilchek, 1976, On the mode of adsorption of proteins to ‘hydrophobic columns’, Biochem. biophys. Res. Commun., 72, 108, 10.1016/0006-291X(76)90967-0 Youngner, 1973, Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity, J. Immunol., 111, 1914, 10.4049/jimmunol.111.6.1914 Zajac, 1969, Autogenous and virus-induced interferons from lines of lymphoblastoid cells, Cancer Res., 29, 1467